NEKTAR THERAPEUTICS Quarterly Operating Lease, Liability in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Nektar Therapeutics quarterly Operating Lease, Liability history and growth rate from Q4 2018 to Q4 2023.
  • Nektar Therapeutics Operating Lease, Liability for the quarter ending December 31, 2023 was $118M, a 10.4% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $118M -$13.7M -10.4% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $131M -$11.7M -8.16% Dec 31, 2022 10-K 2023-02-28
Q4 2021 $143M -$7.11M -4.73% Dec 31, 2021 10-K 2022-03-01
Q4 2020 $150M -$4.96M -3.19% Dec 31, 2020 10-K 2021-02-26
Q4 2019 $155M +$59M +61.4% Dec 31, 2019 10-K 2020-02-28
Q3 2019 $154M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $98.6M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $96.7M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $96.2M Jan 1, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.